Tap Consulting, LLC Pfizer Inc Transaction History

Tap Consulting, LLC

$456 Million
Q2 2024

A detailed history of Tap Consulting, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Tap Consulting, LLC holds 8,504 shares of PFE stock, worth $243,299. This represents 0.05% of its overall portfolio holdings.

Number of Shares

8,504

Previous 8,132 4.57%

Holding current value

$243,299

Previous $225,000 5.33%

% of portfolio

0.05%

Previous 0.05%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$25.26 - $29.6 $9,396 - $11,011	372 Added 4.57%	8,504 $237,000
Q1 2024 Apr 22, 2024	SELL	$25.89 - $29.73 $6,524 - $7,491	-252 Reduced 3.01%	8,132 $225,000
Q4 2023 Feb 02, 2024	BUY	$26.13 - $33.94 $2,613 - $3,394	100 Added 1.21%	8,384 $241,000
Q3 2023 Dec 05, 2023	SELL	$32.09 - $37.51 $229,507 - $268,271	-7,152 Reduced 46.33%	8,284 $274,000
Q2 2023 Jul 19, 2023	SELL	$36.12 - $41.79 $20,552 - $23,778	-569 Reduced 3.56%	15,436 $566,000
Q1 2023 Apr 18, 2023	SELL	$39.39 - $51.28 $35,726 - $46,510	-907 Reduced 5.36%	16,005 $653,000
Q4 2022 Jan 23, 2023	BUY	$41.75 - $54.5 $2,880 - $3,760	69 Added 0.41%	16,912 $0
Q3 2022 Oct 12, 2022	BUY	$43.76 - $53.42 $3,588 - $4,380	82 Added 0.49%	16,843 $737,000
Q2 2022 Jul 26, 2022	SELL	$46.53 - $55.17 $14,750 - $17,488	-317 Reduced 1.86%	16,761 $879,000
Q1 2022 Apr 26, 2022	SELL	$45.75 - $56.69 $199,561 - $247,281	-4,362 Reduced 20.35%	17,078 $884,000
Q4 2021 Jan 27, 2022	BUY	$41.32 - $61.25 $32,353 - $47,958	783 Added 3.79%	21,440 $1.27 Million
Q3 2021 Nov 03, 2021	BUY	$39.25 - $50.42 $942 - $1,210	24 Added 0.12%	20,657 $888,000
Q2 2021 Aug 06, 2021	BUY	$35.91 - $40.68 $8,833 - $10,007	246 Added 1.21%	20,633 $808,000
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $6,564 - $7,402	196 Added 0.97%	20,387 $739,000
Q4 2020 Jan 19, 2021	BUY	$33.47 - $42.56 $135,319 - $172,070	4,043 Added 25.04%	20,191 $743,000
Q3 2020 Oct 20, 2020	SELL	$31.75 - $37.25 $2,540 - $2,980	-80 Reduced 0.49%	16,148 $593,000
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $26,535 - $32,191	-881 Reduced 5.15%	16,228 $531,000
Q1 2020 Apr 29, 2020	BUY	$27.03 - $38.62 $27,921 - $39,894	1,033 Added 6.43%	17,109 $558,000
Q4 2019 Jan 27, 2020	SELL	$32.92 - $37.36 $6,880 - $7,808	-209 Reduced 1.28%	16,076 $630,000
Q3 2019 Nov 08, 2019	BUY	$32.49 - $42.13 $15,400 - $19,969	474 Added 3.0%	16,285 $585,000
Q1 2019 May 03, 2019	BUY	$37.5 - $41.2 $592,912 - $651,413	15,811 New	15,811 $671,000

Others Institutions Holding PFE

# of Institutions

3,222

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $161B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tap Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tap Consulting, LLC with notifications on news.

Account

Tap Consulting, LLC Pfizer Inc Transaction History